Reckitt Benckiser Group (LON:RKT) Rating Reiterated by HSBC

HSBC reissued their hold rating on shares of Reckitt Benckiser Group (LON:RKT) in a report published on Thursday, MarketBeat.com reports.

Reckitt Benckiser Group Trading Down 0.2 %

RKT opened at GBX 4,130 ($51.41) on Thursday. The business has a 50 day simple moving average of GBX 4,895.57 and a two-hundred day simple moving average of GBX 5,336.67. The firm has a market capitalization of £29.26 billion, a price-to-earnings ratio of 1,823.35, a PEG ratio of 3.76 and a beta of 0.07. The company has a debt-to-equity ratio of 100.80, a current ratio of 0.64 and a quick ratio of 0.46. Reckitt Benckiser Group has a one year low of GBX 4,102.64 ($51.07) and a one year high of GBX 6,570 ($81.79).

Reckitt Benckiser Group Increases Dividend

The firm also recently declared a dividend, which will be paid on Friday, May 24th. Shareholders of record on Thursday, April 11th will be given a dividend of GBX 115.90 ($1.44) per share. This is a positive change from Reckitt Benckiser Group’s previous dividend of $76.60. The ex-dividend date of this dividend is Thursday, April 11th. This represents a yield of 1.99%. Reckitt Benckiser Group’s dividend payout ratio is presently 8,502.20%.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; vaginal care routine products; sore throat medications; and hair removal products under the Clearasil, Dettol, Durex, Gaviscon, Nurofen, Mucinex, Queen V, Strepsils, and Veet brands.